相关实验视频

Updated: Jul 21, 2025

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

精准医学和心脏通道病变:人类iPSC率先行动

Sneha Annie Sebastian¹, Venkatesh Panthangi², Yashendra Sethi³

¹Department of Internal Medicine, Azeezia Medical College, Kollam, Kerala, India.

Current problems in cardiology

|July 26, 2023

概括

心脏突然死亡 (SCD) 是一个主要的全球健康问题,通常是由年轻人的遗传离子通道疾病引起的. 本综述探讨了诊断和管理这些疾病的进展,包括精准医学和人工智能应用.

科学领域:

心脏病学心脏病学
遗传学遗传学是一个
分子生物学分子生物学

背景情况:

心脏突然死亡 (SCD) 是全球死亡的一个重要原因,特别是在年轻人群中.
在35岁以下的人群中,突然意外死亡的很大比例缺乏尸检后的结构性心脏异常,这意味着遗传性离子通道病变.
已公认的遗传通道病包括长QT综合征 (LQTS),布鲁加达综合征 (BrS),短QT综合征 (SQTS) 和 катехолами内尔多形心室性心跳动 (CPVT).

研究的目的:

审查心脏离子通道疾病的鉴定,风险分层和临床管理方面的关键挑战和最近的进展.
突出精准医学 (PM) 和人工智能 (AI) 在理解遗传机制方面的作用.
强调人类诱导多能干细胞 (iPSC) 平台在通道病变中解决耐火性临床问题的实用性.

主要方法:

关于心脏离子通道疾病的最新进展的文献综述.
对遗传检测,风险分层和临床管理策略的分析.
探索精密医学,人工智能和基于iPSC的平台.

主要成果:

了解离子通道病遗传学的重大进展改善了SCD的早期诊断和预防.
新兴的PM和AI应用为理解遗传基础提供了新的途径.
基于iPSC的平台在解决与这些疾病相关的复杂临床挑战方面表现有前途.

结论:

心脏离子通道病变是急性心脏死亡的关键原因,通常是基因决定的.
基因理解的进步,加上PM和AI,正在增强诊断和治疗方法.
iPSC 技术为阐明疾病机制和开发向治疗提供了强大的工具.

更多相关视频

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Published on: January 17, 2020

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...